NDC 10135-735

PYRAZINAMIDE

Pyrazinamide Tablet

PYRAZINAMIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Marlex Pharmaceuticals, Inc. The primary component is Pyrazinamide.

Product ID10135-735_db250a85-2e21-87e9-e053-2a95a90a72b6
NDC10135-735
Product TypeHuman Prescription Drug
Proprietary NamePYRAZINAMIDE
Generic NamePyrazinamide Tablet
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-03-01
Marketing CategoryANDA /
Application NumberANDA080157
Labeler NameMARLEX PHARMACEUTICALS, INC
Substance NamePYRAZINAMIDE
Active Ingredient Strength500 mg/1
Pharm ClassesAntimycobacterial [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 10135-735-01

100 TABLET in 1 BOTTLE (10135-735-01)
Marketing Start Date2022-03-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PYRAZINAMIDE" or generic name "Pyrazinamide Tablet"

NDCBrand NameGeneric Name
0904-6696PyrazinamidePyrazinamide
10135-735PYRAZINAMIDEpyrazinamide tablet
33342-447PyrazinamidePyrazinamide
50090-0520PyrazinamidePyrazinamide
50090-0521PyrazinamidePyrazinamide
50090-5963PyrazinamidePyrazinamide
55695-026PyrazinamidePyrazinamide
60687-138PyrazinamidePyrazinamide
61748-012PyrazinamidePyrazinamide
67253-660PyrazinamidePyrazinamide
70518-0085PyrazinamidePyrazinamide
70518-2534PyrazinamidePyrazinamide
70954-484PyrazinamidePyrazinamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.